RPCEC00000352已完成未知
Safety and efficacy study of the natural product Curmeric-nasal in a quarantined community of primary care due to possible cases of COVID-19.
Center for Technological Applications and Nuclear Development (CEADEN)0 个研究点目标入组 148 人开始时间: 2021年1月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 148
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 5 years 至 85 years（—）
- 性别
- All
入选标准
- •Inhabitants of the area in quarantine because of COVID-19 in primary health care.
排除标准
- •Known allergy to Turmeric.
研究者
相似试验
已完成
不适用
Curmeric- Safety-Efficacy- Community-Quarantine-COVID-19COVID-19SARS-CoV2Nidovirales InfectionsCoronaviridae InfectionsCoronavirus InfectionsSARS VirusDisease PreventionBetacoronavirusRPCEC00000351Center for Technological Applications and Nuclear Development (CEADEN)340
尚未招募
不适用
This study will investigate the anticancer effect and treatment-related safety when focused ultrasound stimuli is given for the pancreatic cancer in patients with unresectable pancreatic cancer who need chemotherapy in a prospective mannerNeoplasmsKCT0006302Seoul National University Hospital60
招募中
2 期
A clinical study to evaluate the comparative efficacy of three Unani drugs in the treatment of Hepatitis B carriersCTRI/2018/06/014642DG Central Council for Research in Unani Medicine
已完成
2 期
A study investigating the efficacy and safety of CNS prophylaxis with R-CHOP and high-dose methotrexate in patients with de novo diffuse large B-cell lymphoma who have high risk for CNS relapse.Diffuse large B-cell lymphomaJPRN-UMIN000013540Department of Hematology and Oncology, Osaka University Graduate School of Medicine100
已完成
不适用
The clinical trials for safety and usefulness of chronic hepatitis therapeutics,agent 3-oxygelmillpropionic acid polymer for the advanced and recurrent colorectal cancer of having the existing chemotherapeutic refractory or intolerance.(Phase 1 test)JPRN-UMIN000022129Osaka University Hospital5